Interestingly, the authors employed a CRISPR-activated adenoviral delivery system to overexpress NEAT1 in vivo in murine corneal endothelial cells and discovered that this could preserve the cells’ morphology, architecture, and density, thereby preventing FECD development despite UVA irradiation exposure. The gene discussed is NEAT1; the disease is Fuchs endothelial corneal dystrophy.